Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.70 |
| ▸ | SQLE | Q14534 | 7/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | FNTA | P49354 | 1/20 | 0.55 |
| ▸ | FNTB | P49356 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3092587 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL28731350 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL12377558 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL12713311 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL3090338 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL6716175 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL17047981 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL10510234 | 1.00 | KMT2A (0.80) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL27916633 | 0.97 | KMT2A (0.76) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL2987781 | 0.95 | KMT2A (0.70) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114555104-A | Herbal preparation for stimulating hair growth, controlling hair loss, dandruff and infections thereof using ageratum species | GE营养有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-112513263-B | Method for producing a compound of a foliol | 弗门尼舍有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-112789354-B | Process for producing a drimenoalkyl acetate compound | 弗门尼舍有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-115703697-A | Novel organic alkoxide agglomerate and preparation method and application thereof | 上海科技大学 | 2023-02-17 | — | — | CN | disclosed |
| CN-115697956-A | Preparation method of quinone compound | 上海科技大学 | 2023-02-03 | — | — | CN | disclosed |
| CN-113735696-B | Preparation method of quinone compound | 上海科技大学 | 2022-11-08 | — | — | CN | disclosed |
| CN-110475474-B | Compounds and methods of use | 西格纳姆生物科学公司 | 2022-11-04 | — | — | CN | disclosed |
| US-11447724-B2 | Compositions that include siloxane compounds having pendant silyl ether moieties | THE PROCTER & GAMBLE COMPANY (US) | 2022-09-20 | — | — | US | disclosed |
| EP-4013862-A2 | NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS | Firmenich SA (CH) | 2022-06-22 | — | — | EP | disclosed |
| US-20220177813-A1 | TREATMENT COMPOSITIONS WITH PRO-FRAGRANCE SILICONE POLYMERS THAT COMPRISE HETEROCYCLIC MOIETIES | THE PROCTER & GAMBLE COMPANY | 2022-06-09 | — | — | US | disclosed |
| WO-2016077513-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2016-05-19 | — | — | WO | disclosed |
| US-20160137674-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2016-05-19 | — | — | US | disclosed |
| WO-2015128428-A1 | PHEROMONE DISPENSER MADE OF PLASTIC MATERIAL | BASF SE (DE) | 2015-09-03 | — | — | WO | disclosed |
| US-8629268-B2 | Cyclisation process of forming a multiple ring compound | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2014-01-14 | — | — | US | disclosed |
| US-20130046090-A1 | CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2013-02-21 | — | — | US | disclosed |
| US-8227645-B2 | Cyclisation process of forming a multiple ring compound | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2012-07-24 | — | — | US | disclosed |
| US-20100228058-A1 | CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2010-09-09 | — | — | US | disclosed |
| WO-2007097719-A1 | CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2007-08-30 | — | — | WO | disclosed |
| US-4116955-A | META-CYCLOPHANE AND A TRANS-TERPENOID, SEPARATION OF ISOMERS | TEIJIN LIMITED (JP) | 1978-09-26 | — | — | US | disclosed |
| US-3969196-A | Process for the separation of mixtures of substances | STUDIENGESELLSCHAFT KOHLE M.B.H. (DT) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137674-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | KMT2A 1800/4885MAPT 904/4885MEN1 49/4885 |
| US-20100228058-A1 | CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND | DHPS, GGPS1, COASY | KMT2A 2281/4885MAPT 4010/4885MEN1 458/4885 |
| US-20130046090-A1 | CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND | COASY, AKR1C4, AKR1C2 | KMT2A 1729/4885MAPT 3702/4885MEN1 541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.